| LA | HB870 | Pass | Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
[Detail][Text][Discuss] | 2026-06-12
Effective date: 08/01/2026. |
| LA | HB1199 | Pass | Provides relative to health insurance coverage for genetic testing and the treatment of SCN2A-associated medical conditions (EN NO IMPACT See Note)
[Detail][Text][Discuss] | 2026-06-09
Effective date: 06/09/2026. |
| LA | HB291 | Pass | Prohibits health insurers from taking adverse payment or contracting actions against participating facilities based solely on another provider's network status (EN INCREASE EX See Note)
[Detail][Text][Discuss] | 2026-06-08
Effective date: 06/08/2026. |
| LA | HB766 | Pass | Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
[Detail][Text][Discuss] | 2026-06-08
Effective date: 08/01/2026. |
| LA | HB1235 | Pass | Modifies provisions of law regarding health insurance coverage of prosthetic and custom orthotic devices and services (EN INCREASE EX See Note)
[Detail][Text][Discuss] | 2026-06-03
Effective date: 06/03/2026. |
| LA | HB1196 | Pass | Provides relative to coverage of colorectal cancer screening, colonoscopies, and associated preventive services (EN NO IMPACT See Note)
[Detail][Text][Discuss] | 2026-06-02
Effective date: 08/01/2026. |
| LA | HB1176 | Pass | Requires that Medicare Advantage plans provide insurance coverage for integrative care services (EN SEE FISC NOTE See Note)
[Detail][Text][Discuss] | 2026-06-02
Effective date: 01/01/2027. |
| LA | HB557 | Pass | Provides relative to long-term care pharmacy
[Detail][Text][Discuss] | 2026-05-29
Effective date: 08/01/2026. |
| LA | HB938 | Engross
Sine Die | Provides relative to pharmacy benefit managers (RE +$3,187,173 SG EX See Note)
[Detail][Text][Discuss] | 2026-05-14
To Senate Finance Committee |
| LA | HB774 | Engross
Sine Die | Provides relative to insurance coverage for hearing aids (EG1 INCREASE GF EX See Note)
[Detail][Text][Discuss] | 2026-04-27
To Senate Finance Committee |
| LA | HB477 | Intro
Sine Die | Modifies provisions of law regarding health insurance coverage of prosthetic and custom orthotic devices and services (OR INCREASE EX See Note)
[Detail][Text][Discuss] | 2026-04-09
Becomes HB 1235. |
| LA | HB919 | Engross
Sine Die | Provides relative to pharmacy benefit managers (RE +$238,163 SG EX See Note)
[Detail][Text][Discuss] | 2026-04-01
To Senate Insurance Committee |
| LA | HB95 | Intro
Sine Die | Provides relative to health insurance coverage with respect to certain claims
[Detail][Text][Discuss] | 2026-03-09
To House Civil Law and Procedure Committee |
| LA | HB771 | Intro
Sine Die | Provides relative to Medicare as the secondary payer for retirees with employer-sponsored health insurance (OR NO IMPACT See Note)
[Detail][Text][Discuss] | 2026-03-09
To House Insurance Committee |
| LA | HB869 | Intro
Sine Die | Provides relative to expand glucose-improving medications coverage to individuals based on body mass index (OR INCREASE EX See Note)
[Detail][Text][Discuss] | 2026-03-09
To House Insurance Committee |
| LA | HB920 | Intro
Sine Die | Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)
[Detail][Text][Discuss] | 2026-03-09
To House Insurance Committee |
